Beth A. Tarini, MD, MS
Assistant Professor, Department of Pediatrics and Communicable Diseases
300 North Ingalls 6C11
Dr. Tarini’s research focuses on the communication process and the health outcomes associated with genetic testing in pediatrics. She is particularly interested in pediatric population-based screening programs, such as newborn screening. Through her research, Dr. Tarini seeks to optimize communication about genetic testing between parents and providers in an effort to maximize health and minimize harm.
Dr. Tarini is a current member of the American Academy of Pediatrics Committee on Genetics.
M.S., Health Services, University of Washington, 2006
M.D., Albert Einstein College of Medicine, 2001
B.A., Biology, Harvard University, 1997
RWJ Clinical Scholars Program, University of Washington, 2004-2006
Pediatrics, Seattle Children's Hospital, University of Washington 2001-2004
Genetic services in primary care pediatrics: a survey of the quality improvement innovation networks' physicians.
Genetics in Medicine. (Under Review).
Family history in primary care pediatrics.
Pediatrics. (In Press).
Effects of undergoing multiplex genetic susceptibility testing on parent's attitudes towards testing their children.
Ann Behav Med. (In Press).
Screening practices for identifying type 2 diabetes in adolescents.
J Adol Health. (In Press).
Parental Interest in Whole Genome Sequencing of Newborns.
Genetics in Medicine. 2013 Jun 6. [Epub ahead of print].
Effects of Hypothetical Type 2 Diabetes Genetic Testing on Parents' Efforts to Prevent Diabetes in Children.
Clinical Pediatrics. 2013 May 14. [Epub ahead of print].
The Perils of SNP Array Testing: Uncovering Unexpected Consanguinity.
Pediatric Neurology. Volume 49, Issue 1, July 2013, Pages 50-53.
Growing Up in the Genomic Era: Implications of Whole-Genome Sequencing for Children, Families, and Pediatric Practice.
Annu. Rev. Genomics Hum. Genet. 2013 Jul 15. [Epub ahead of print].
A Clinical Risk Score for Identifying Adolescents with Dysglycemia.
Journal of Pediatric Endocrinology and Metabolism. 2013;26(5-6):477-88.
Anticipating the Arrival of Low Penetrance Genetic Testing to Primary Care Medicine.
J Comm Genetics. 2013; 4(2): 285-288.
Influence of “GERD” label on parents’ decision to medicate infants with excessive crying and reflux.
Pediatrics. 2013 May;131(5):839-45.
Lessons that newborn screening in the USA can teach us about biobanking and large-scale genetic studies.
Personalized Medicine. 2013 Jan; 10(1):81-87.
Ethical Issues in Neonatal and Pediatric Clinical Trials.
Pediatr Clin North Am. 2012 Oct;59(5):1205-20. Epub 2012 Aug 26.
Blindness in Walnut Grove: How did Mary Ingalls lose her sight?
Ethical Issues with Newborn Screening in the Genomics Era.
Annu Rev Genomics Hum Genet. 2012 Sep 22;13:381-93. Epub 2012 May 1.
Decision Analysis, Economic Evaluation, and Newborn Screening: Challenges and Opportunities.
Genetics in Medicine. 2012;14(8):703-712.
A Policy Impact Analysis of the Mandatory NCAA Sickle Cell Trait Screening Program
Health Services Research. 2012 Feb;47(1 Pt 2):446-61.
Children and Predictive Genomic Testing: Disease Prevention, Research Protection, and Our Future.
Journal of Pediatr Psychol. 2011 Nov-Dec;36(10):1113-21. Epub 2011 Aug 4.
False Positive Newborn Screening Result and Future Healthcare Use in a State Medicaid Cohort.
Pediatrics. 2011 Oct;128(4):715-22. Epub Sep 19.
Epidemiol Rev. 2011;33(1):148-64.
Genetic Testing and Youth Sports.
Diagnosis of Diabetes Using Hemoglobin HbA1c: Should Recommendations in Adults Be Extrapolated to Adolescents?
Journal of Pediatrics 2011;158(6):947-952.e1-3. Epub 2010 Dec 30.
Not Without My Permission: Parents’ Willingness to Permit Use of Newborn Screening Samples for Research.
Public Health Genomics 2010;13(3):125-30. Epub 2009 Jul 11.
Parents Interest in Predictive Genetic Testing for Their Children When a Disease Has No Effective Treatment.
Pediatrics 2009; 124 (3):e432-e438.
Afraid in the Hospital: Parental concern for errors during a child’s hospitalization.
J Hosp Med 2009 Nov 4(9):521-7.
Parents’ concerns about their own and their child’s risk of disease: potential effects of family history vs. genetic test results.
Arch Pediatr Adolesc Med 2008;162:1079-83.
Waiving informed consent in newborn screening research: balancing social value and respect.
Am J Med Genet C Semin Med Genet. 2008; Feb 148C(1):23-30.
Towards family-centered inpatient medical care: the role of parents as participants in medical decisions.
J Pediatrics 2007;151(6):690-95.
The current revolution in newborn screening: new technology, old controversies.
Arch Pediatr Adolesc Med. 2007;161(8):767-72.
Keeping up with the newborn screening revolution.
Contemp Pediatr 2007;24(4):36-48.
State newborn screening in the era of tandem mass spectrometry: more tests, more false positive results.
Systematic review of the relationship between timing of introduction of solid foods to infants and the development of allergic disease.
Arch Pediatr Adolesc Med. 2006;160(5):502-7.
Does presentation format at the Pediatric Academic Societies’ Annual Meeting predict subsequent publication?
Pediatrics. 2003;112(6 Pt 1):1238-41.